Cite

HARVARD Citation

    Faaborg, L. et al. (2016). A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group. Acta oncologica. pp. 234-239. [Online]. 
  
Back to record